1Leek RD.Bcl-2 in normal human breast and carcinoma,association with oestrogen receptor-positive,epidermal growth factor receptor-negative tumours and in situ cancer.Br J Cancer,1994,69∶135.
2Sierra A,Castellsague X,Escobedo A,et al.Bcl-2 with loss of apoptosis allows accumulation of genetic alterations:a pathway to metastatic progression in human breast cancer.Int J Cancer,2000,89∶142-147.
3Ralph S,David ML.In search of the tumour-suppressor functions of BRCA1 and BRCA2.Nature,2000,408∶429-432.
4Miki Y,Swensen J, Shattuck Eidens D,et al.A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.Science,1994,26∶66.
5David C,Yi W,Jun Q,et al.Requirement of ATM-dependent phosphorylation of BRCA1 in the DNA damage response to double-strand breaks.Science,1999, 286∶1162-1166.
6Deng CX ,Brodie SG.Roles of BRCA1 and its interacting proteins.Bioessays,2000,22∶728-737.
7Welcsh PL,Owens KN,King MC.Insight into the function of BRCA1 and BRCA2.Trends Genet,2000,16∶69-74.
8Chen JJ,Sliver D,Cantor S,et al.BRCA1,BRCA2,and Rad51 operate in a common DNA damage pathway.Cancer Res,1999,59(7 Suppl)∶1752-1756.
9Scully R.Genetic analysis of BRCA1 function in a defined tumour cell line.Mol Cell,1999,4∶1093-1099.
10Cordeiro-Stone M,Makhov AM,Zaritskaya LS,et al.Analysis of DNA replication forks encountering a pyrimidine in the template to the leading strand.J Mol Biol,1999,289∶1207-1218.
